TherapeuticsMD
(NASDAQ) TXMD
TherapeuticsMD Financials at a Glance
Market Cap
$23.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$3.35M
Net Income (TTM)
$179.00K
EPS (TTM)
$0.02
P/E Ratio
129.87
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$1.95
Volume
13,180
Open
$2.00
Price
$1.95
Volume
13,180
Open
$2.00
Previous Close
$2.00
Daily Range
$1.95 - $2.06
52-Week Range
$0.99 - $2.95
Estimated Earnings Date
Aug 17, 2026
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$1.95
Volume
13,180
Open
$2.00
Previous Close
$2.00
Daily Range
$1.95 - $2.06
52-Week Range
$0.99 - $2.95
Estimated Earnings Date
Aug 17, 2026
TXMD News
3 Drug Stocks That Could Soar in 2020
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TherapeuticsMD
Industry
Pharmaceuticals
Sector
Health CareEmployees
1
CEO
Marlan D. Walker
Website
www.therapeuticsmd.comHeadquarters
Boca Raton, FL 33431, US
TXMD Financials
Key Financial Metrics (TTM)
Gross Margin
90.31%
Operating Margin
-111.66%
Net Income Margin
5.34%
Return on Equity
0.66%
Return on Capital
-12.78%
Return on Assets
0.48%
Earnings Yield
0.77%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
11.57M
Volume
13.18K
Avg. Volume
39.79K
Financials (TTM)
Gross Profit
$3.03M
Operating Income
-$3.74M
EBITDA
-$3.43M
Operating Cash Flow
$2.67M
Capital Expenditure
$0.00
Free Cash Flow
$2.67M
Cash & ST Invst.
$8.42M
Total Debt
$5.83M
TherapeuticsMD Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$724.00K
+84.2%
Gross Profit
$399.00K
+1.5%
Gross Margin
55.11%
N/A
Market Cap
$23.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$23.15M
N/A
Employees
1
N/A
Net Income
$95.00K
+114.5%
EBITDA
-$112.00K
+89.8%
Quarterly Fundamentals
Total Cash
$8.42M
+46.5%
Total Debt
$5.83M
-16.4%
Accounts Receivable
$3.21M
+7.2%
Inventory
$0.00
N/A
Long Term Debt
$4.82M
-19.1%
Short Term Debt
$1.01M
-0.4%
Return on Assets
0.48%
N/A
Return on Invested Capital
-11.46%
N/A
Free Cash Flow
$936.00K
+36.4%
Operating Cash Flow
$936.00K
+36.4%